PYPD
PolyPid Ltd.NASDAQHealthcare$4.39-3.42%ClosedMarket Cap: $44.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
7.96
P/S
0.00
EV/EBITDA
-1.22
DCF Value
$0.12
FCF Yield
0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-291.4%
ROA
-153.2%
ROIC
-95.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $8.5M | $-8.5M | $-0.41 | — |
| FY 2025 | $0.00 | NaN% | $-33.0M | $-34.2M | $-2.09 | — |
| Q3 2025 | $0.00 | NaN% | $-7.5M | $-7.5M | $-0.37 | — |
| Q2 2025 | $0.00 | NaN% | $-9.4M | $-10.0M | $-0.78 | — |
| Q1 2025 | $0.00 | NaN% | $-7.6M | $-8.3M | $-0.70 | — |
| Q4 2024 | $0.00 | NaN% | $-8.2M | $-8.5M | $-1.13 | — |
| FY 2024 | $0.00 | NaN% | $-28.0M | $-29.0M | $-4.91 | — |
| Q3 2024 | $0.00 | NaN% | $-7.4M | $-7.8M | $-1.22 | — |
| Q2 2024 | $0.00 | NaN% | $-6.1M | $-6.3M | $-1.25 | — |
| Q1 2024 | $0.00 | NaN% | $-6.3M | $-6.4M | $-1.37 | — |
| Q4 2023 | $0.00 | NaN% | $-6.0M | $-6.4M | $-3.84 | — |
| FY 2023 | $0.00 | NaN% | $-22.9M | $-23.9M | $-16.99 | — |